PlexusDx supports long-term management through ongoing dose adjustments, HSA/FSA eligibility for lower out-of-pocket costs, and access to genetic insights that help explain your individual response patterns
At the data cut-off date, 306 patients (3.5% of the FAS) in the semaglutide 2.4 mg group and 1,059 patients (12.0% of the FAS) in the placebo group experienced a first occurrence of hemoglobin A1C of 6.5% or greater (HR = 0.27
You should never be charged to participate in a sponsored clinical trial
Both represent meaningful improvements, but the 15-pound difference translates to additional health benefits
The permeabilization of the MOM due to MPT releases apoptogenic proteins such as cytochrome c, second mitochondria-derived activator of caspase (Smac), apoptosis inducing factor (AIF), and endonuclease G from the intermembrane space